Although a trend was observable suggesting that patients with higher CXCR4 clonality (CCF > 50%) experienced inferior PFS and OS outcomes compared with those with lower CXCR4 clonality (CCF < 50%), the impact of varying CCF did not reach statistical significance (PFS: P = 0.741; OS: P = 0.521; Supplementary Fig.
← all excerpts
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia.
1
0.7410
0.7410